Adams Diversified Equity Fund, Inc. / ABT
Adams Diversified Equity Fund, Inc.’s Abbott Laboratories Position
Does Adams Diversified Equity Fund, Inc. own Abbott Laboratories (ABT)? Not currently — the last reported position was 265.2K shares worth $29M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$29M
Q2 2023
Shares
265.2K
% of Portfolio
+1.20%
Quarters Held
14
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 265.2K | $29M | +1.20% |
| Q2 2022 | 269.4K | $29M | +1.39% |
| Q1 2022 | 269.4K | $32M | +1.27% |
| Q2 2021 | 116.8K | $14M | +0.53% |
| Q1 2021 | 256.4K | $31M | +1.31% |
| Q4 2020 | 256.4K | $28M | +1.27% |
| Q3 2020 | 256.4K | $28M | +1.36% |
| Q2 2020 | 225.0K | $21M | +1.09% |
| Q1 2020 | 225.0K | $18M | +1.12% |
| Q4 2019 | 160.1K | $14M | +0.72% |
| Q3 2019 | 365.0K | $31M | +1.63% |
| Q2 2019 | 342.8K | $29M | +1.53% |
| Q1 2019 | 376.1K | $30M | +1.65% |
| Q4 2018 | 421.7K | $31M | +1.88% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Adams Diversified Equity Fund, Inc.’s full portfolio or all institutional holders of ABT.